Zyban, Wellbutrin, Bupropion
Zyban, Wellbutrin, Bupropion Newswire

Zyban, Wellbutrin, Bupropion Newswire

Comprehensive Real-Time News Feed for Zyban, Wellbutrin, Bupropion (generic).

Results 1 - 20 of 128 in Zyban, Wellbutrin, Bupropion (generic)

  1. E-quittingRead the original story w/Photo

    Wednesday Feb 3 | McGill Reporter

    Although the holidays may seem like a distant memory, statistically speaking, most of us are still sticking with our New Year's resolutions. For many, that means quitting smoking - and they're hoping that electronic cigarettes will help.

    Comment?

  2. Antidepressant Use Common Among Reproductive-Aged WomenRead the original story

    Thursday Jan 28 | Freshnews

    More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008-2013, according to a new analysis published today in the Centers for Disease Control and Prevention 's Morbidity and Mortality Weekly Report . January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies.

    Comment?

  3. Comparison of smoking cessation therapies finds similar quit ratesRead the original story w/Photo

    Tuesday Jan 26 | PhysOrg Weblog

    Among adults motivated to quit smoking, 12 weeks of treatment with a nicotine patch, the drug varenicline, or combination nicotine replacement therapy produced no significant differences in confirmed rates of smoking abstinence at 26 or 52 weeks, raising questions about the current relative effectiveness of intense smoking cessation pharmacotherapies, according to a study in the January 26 issue of JAMA . Due to the profound health effects of tobacco smoking, it is important to identify treatments that increase rates of long-term smoking abstinence.

    Comment?

  4. Global Smoking Cessation and Nicotine De-Addiction Products Market to ...Read the original story w/Photo

    Tuesday Jan 26 | SBWire

    Transparency Market Research, a global market intelligence firm has recently announced the publication of a new market research report. The research report, titled "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019", provides a complete analysis of the global smoking cessation and nicotine de-addiction products market.According to the research report, in 2012, the global smoking cessation and nicotine de-addiction products market was worth US$5.1 bn and is anticipated to reach US$16.02 bn by 2019, exhibiting a healthy 8.70% CAGR between 2013 and 2019.

    Comment?

  5. .com | How to Stop SmokingRead the original story w/Photo

    Thursday Jan 21 | News24

    Smokers are responsible for a large share of medical costs. They have more heart attacks, more strokes, more hypertension, worsened diabetes control, higher cholesterol levels, a greater incidence of infectious diseases, more lung diseases, poor healing of wounds, and higher rates of cancer, to name a few problems that the habit of smoking causes.

    Comment?

  6. Global Smoking Cessation and Nicotine De-Addiction Products Market to Be Worth US$20.8 Bn by 2023Read the original story w/Photo

    Tuesday Jan 19 | SBWire

    Transparency Market Research has published a new market report titled, "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023." According to the report, global smoking cessation and nicotine de-addiction products market was valued at US$ 6.5 Bn in 2014 and is anticipated to expand at a CAGR of 13.7% from 2015 to 2023 to reach US$ 20.5 Bn by 2023.

    Comment?

  7. Smoking Cessation and Nicotine De-addiction Products Market to be...Read the original story

    Monday Jan 18 | Sys-Con Media

    Transparency Market Research has published a new market report titled, "Smoking Cessation and Nicotine De-addiction Products Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023." According to the report, global smoking cessation and nicotine de-addiction products market was valued at Smoking cessation or nicotine de-addiction can be achieved by various modes such as nicotine replacement products, e-cigarettes, anti-depressants and nicotine receptor agonists such as Zyban , and Chantix/Champix .

    Comment?

  8. Medicaid tobacco cessation: Big gaps remain in efforts to get smokers to quitRead the original story

    Friday Jan 15 | Insurance News Net

    "Data from the coverage currently smoke, a rate that is roughly twice as high as that for the general public, Ku says. Smokers covered by who don't get the help they need to quit are at high risk of lung cancer, heart disease and other serious health problems, he says.

    Comment?

  9. Orexigen Announces 2016 Financial Outlook And Key PrioritiesRead the original story

    Sunday Jan 10 | BioSpace

    "In 2015, Contrave quickly established its position as market leader among branded obesity medicines, Mysimba became one of three approved weight loss medicines in , and Orexigen signed a South Korean distributorship agreement with Kwang Dong Pharmaceuticals, which is a model for our preferred partnership structure for most markets outside . Sources of cash include revenue and royalties derived from net product sales of Contrave and Mysimba in the U.S., in non-cash expenses, and will be used to fund research and development, global commercialization of Contrave and Mysimba, and general and administrative costs.

    Comment?

  10. Bloomberg Hits Valeant With Ill-Informed ArticleRead the original story w/Photo

    Monday Jan 11 | Seeking Alpha

    The article ignored a few very important details about Wellbutrin, namely that some of its generic copies have been proven to be dangerous. This unfortunate unawareness led the authors on the wrong track and caused them to suggest answers which are totally off the mark.

    Comment?

  11. Orexigen Names As EVP, General Counsel & Secretary And As EVP, Global Human ResourcesRead the original story

    Sunday Jan 10 | BioSpace

    Lynch is a veteran legal professional with more than a decade of experience in the life sciences industry as well as six years of general corporate practice. Lynch will assume responsibility for the company's global legal affairs and compliance operations.

    Comment?

  12. Gaps Remain Among States' Medicaid Efforts To Help People Kick Smoking HabitRead the original story w/Photo

    Sunday Jan 10 | KTOO-TV Juneau

    The 2010 federal health law has a provision that was supposed to make it easier for people on Medicaid to quit smoking. But in a number of states, it's not, so far, having widespread success.

    Comment?

  13. Orexigen Therapeutics names Thomas Lynch as EVP, General Counsel &...Read the original story

    Jan 8, 2016 | Sys-Con Media

    Lynch is a veteran legal professional with more than a decade of experience in the life sciences industry as well as six years of general corporate practice. Lynch will assume responsibility for the company's global legal affairs and compliance operations.

    Comment?

  14. 1 in 10 Medicaid Recipients Gets Drugs to Quit SmokingRead the original story w/Photo

    Jan 6, 2016 | MedlinePlus

    Roughly one in 10 U.S. smokers using Medicaid insurance gets medications to help quit smoking, with a wide variation between states, a new study finds. Under the Affordable Care Act, state Medicaid programs must cover at least some counseling and approved therapies such as nicotine gum and anti-smoking drugs such as bupropion and varenicline .

    Comment?

  15. Getting Smokers To Quit With The Force Of MedicaidRead the original story w/Photo

    Jan 5, 2016 | Scientific Blogging

    When government pays for your health care, they get the right to tell you what behavior can be detrimental to your health - but before that they will pay for medication to help them stop smoking. But only 10 percent are doing so.

    Comment?

  16. Medicaid Programs Fall Short When It Comes To Helping Smokers QuitRead the original story w/Photo

    Jan 5, 2016 | News 88.9 KNPR

    Smoking is the #1 cause of premature death and preventable illness in the United States. And since one-third of Medicaid participants smoke, compared to 17 percent of the general population, you'd think the states would be all about helping people in their Medicaid programs to quit.

    Comment?

  17. Medicaid tobacco cessation: Big gaps remain in efforts to get smokers to quitRead the original story w/Photo

    Jan 5, 2016 | PhysOrg Weblog

    The percent of Medicaid smokers receiving cessation prescriptions, 2013. Credit: Source: Ku, Bruen, Steinmetz and Bysshe, Health Affairs, Jan. 2016 A new study, published in the January 2016 issue of Health Affairs , by researchers at Milken Institute School of Public Health at the George Washington University, provides new data on how often state Medicaid programs provide help with smoking cessation.

    Comment?

  18. Somatic Symptom DisorderRead the original story

    Jan 5, 2016 | American Academy of Family Physicians

    The revisions were intended to increase their relevance in the primary care setting. The main feature of this disorder is a patient's concern with physical symptoms that he or she attributes to a nonpsychiatric disease.

    Comment?

  19. Influence of smoking cessation drugs on blood pressure and heart rate ...Read the original story

    Jan 4, 2016 | BioMed Central

    Smoking is the most important reversible cardiovascular risk factor. It is well established that quitting smoking reduces coronary events.

    Comment?

  20. Quitting? Head to your pharmacy for free help, more choicesRead the original story w/Photo

    Jan 2, 2016 | The Penticton Western

    If your New Year's resolution is to quit smoking, all you need to do is visit your local pharmacy, announced Health Minister Terry Lake. As of Jan. 1, 2016, smokers who want to quit no longer need to call HealthLink BC at 8-1-1 to join the British Columbia Smoking Cessation Program.

    Comment?